Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU6V | ISIN: US1897631057 | Ticker-Symbol: C97
Tradegate
25.04.24
08:04 Uhr
1,060 Euro
-0,010
-0,93 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CO-DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
CO-DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,0401,08025.04.
1,0401,10025.04.

Aktuelle News zur CO-DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
02.04.Peering Into Co-Diagnostics' Recent Short Interest2
15.03.Co-Diagnostics, Inc. (CODX) Q4 2023 Earnings Call Transcript1
14.03.Co-Diagnostics Inc reports results for the quarter ended in December - Earnings Summary3
14.03.Co-Diagnostics GAAP EPS of -$1.20 misses by $0.30, revenue of $6.8M misses by $0.08M2
14.03.Co-Diagnostics: Q4 Earnings Insights2
14.03.Co-Diagnostics, Inc. - 10-K, Annual Report2
14.03.Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results977SALT LAKE CITY, March 14, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
► Artikel lesen
14.03.Co-Diagnostics, Inc. - 8-K, Current Report2
13.03.Earnings Preview: Co-Diagnostics2
07.03.Co-Diagnostics JV gains India approval for flu test kit3
07.03.Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test283The clinical laboratory real-time PCR multiplex test was designed using Co-Dx Co-Primers and licensed by the CDSCO for use in diagnostic procedures SALT LAKE CITY, March 7, 2024 /PRNewswire/ --...
► Artikel lesen
27.12.23Co-Diagnostics applies for FDA okay of COVID-19 test, stock rallies 17%12
27.12.23Co-Diagnostics Completes EUA Submission To FDA For Co-Dx PCR Pro5
10.11.23Co-Diagnostics, Inc. (CODX) Q3 2023 Earnings Call Transcript2
09.11.23Co-Diagnostics, Inc. - 10-Q, Quarterly Report1
09.11.23Co-Diagnostics, Inc. - 8-K, Current Report1
09.11.23Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results168Receives grant award from the Bill & Melinda Gates Foundation in the amount of $9.0M for the development of tuberculosis test on Co-Dx PCR platform. SALT LAKE CITY, Nov. 9, 2023 /PRNewswire/ --...
► Artikel lesen
10.08.23Co-Diagnostics, Inc. Reports Second Quarter 2023 Financial Results269Co-Dx receives grant awards from the Bill & Melinda Gates Foundation; NIH RADx® Tech to develop tests on our new Co-Dx PCR Home platform SALT LAKE CITY, Aug. 10, 2023 /PRNewswire/ -- Co-Diagnostics...
► Artikel lesen
11.05.23Co-Diagnostics, Inc. Reports First Quarter 2023 Financial Results315Clinical trials for Co-Dx PCR Home platform remain on track; Solid cash position and grant funding support long-term strategy SALT LAKE CITY, May 11, 2023 /PRNewswire/ -- Co-Diagnostics, Inc....
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2